Madrigal Pharmaceuticals, Inc. ( MDGL) - Key Metrics
MDGL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $14.31 | -$2.61 | -$5.95 | -$5.93 |
| 2025Q3 | $12.78 | -$5.08 | $3.55 | $3.51 |
| 2025Q2 | $9.58 | -$1.90 | -$2.12 | -$2.12 |
| 2025Q1 | $6.21 | -$3.32 | -$4.02 | -$4.02 |
MDGL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -55.76 |
| 2025Q3 | ? | -22.58 |
| 2025Q2 | ? | -39.74 |
| 2025Q1 | ? | -24.98 |
MDGL
Price: $544.51
52 week price:
Earnings Per Share: -13.47 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 132314
Ebitda: -8.4 millionMarket Capitalization: 12.2 billion